Physician profile
Charles Clifford Wright
NPI 1184609729
$4,259.49
in general payments reported to CMS, 2019-2025
39 companies · $598 in 2025
The $598 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $121 · 2021: $740 · 2022: $1,368 · 2023: $794 · 2024: $188 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,580.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,007.91 | 2021-2025 | Interstim |
| Coloplast Corp | $518.81 | 2019-2025 | Titan, Speedicath |
| Antares Pharma, INC. | $314.92 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Astellas Pharma US INC | $224.51 | 2019-2023 | Myrbetriq |
| Blue Earth Diagnostics | $191.04 | 2019-2023 | |
| Myovant Sciences INC. | $185.63 | 2021-2022 | |
| Boston Scientific Corporation | $131.60 | 2020-2025 | Ams 700 |
| Abbvie INC. | $129.07 | 2022-2025 | Botox |
| Axonics, INC. | $124.49 | 2020-2023 | Axonics |
| Teleflex LLC | $119.61 | 2025 | Barrigel |
| Myriad Genetic Laboratories, INC. | $119.43 | 2020-2022 | |
| Janssen Biotech, INC. | $98.22 | 2021-2025 | Erleada |
| Ferring Pharmaceuticals INC. | $81.71 | 2019-2025 | Adstiladrin |
| Urogen Pharma, INC. | $78.08 | 2021-2025 | |
| Photocure INC | $76.95 | 2022-2025 | Cysview |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.